ID

12881

Beschreibung

Documentation part: Table III [Recommendations for core asthma outcomes for NIH- initiated clinical research for children (5­-11 years of age)]. ODM derived from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259286/ Background: Asthma clinical research will highly benefit from standardization of major outcomes in terms of definition and assessment methodology. This will permit useful comparisons across interventional or observational studies and will allow more effective data sharing. Objective: National Institutes of Health (NIH) institutes and the Agency for Healthcare Research and Quality (AHRQ) convened a workshop involving 7 expert subcommittees to propose which asthma outcomes should be assessed with standardized methodology in future asthma clinical research studies. Permission granted by: Michelle Freemer.

Link

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259286/

Stichworte

Versionen (2)
  1. 05.01.16 05.01.16 -
  2. 23.02.16 23.02.16 -
Hochgeladen am

5. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Table III- Core Asthma Outcomes NIH AHRQ for children (5­11 years of age)

Englisch

Table III- Core Asthma Outcomes NIH AHRQ for children (5­11 years of age)

1 Formulare  
Characterization of study population for prospective clinical trials
Beschreibung

Characterization of study population for prospective clinical trials

Alias
UMLS CUI-1
C2348561
UMLS CUI-2
C1880022
UMLS CUI-4
C0008976
Serologic multi­allergen screen (IgE) to define atopic status (also for observational studies)
Beschreibung

Biomarkers Serologic

Datentyp

text

Alias
UMLS CUI [1,1]
C0005516
UMLS CUI [1,2]
C0205473
cACT (childhood Asthma Control Test)
Beschreibung

Composite Scores

Datentyp

text

Alias
UMLS CUI [1,1]
C0449820
UMLS CUI [1,2]
C0205199
Events in the 12 months prior to study entry:
Beschreibung

Exacerbation of asthma

Datentyp

text

Alias
UMLS CUI [1]
C0349790
History of:
Beschreibung

Utilization healthcare; Costs healthcare

Datentyp

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
Spirometry (pre­ and post­ bronchodilator)
Beschreibung

Physiology Pulmonary

Datentyp

text

Alias
UMLS CUI [1,1]
C0031842
UMLS CUI [1,2]
C0024109
Prospective clinical trial efficacy/ effectiveness outcomes
Beschreibung

Prospective clinical trial efficacy/ effectiveness outcomes

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C1280519
Events in the 12 months prior to study entry:
Beschreibung

Exacerbation of asthma

Datentyp

text

Alias
UMLS CUI [1]
C0349790
History of:
Beschreibung

Utilization healthcare; Costs healthcare

Datentyp

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
Beschreibung

medication asthma

Datentyp

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Spirometry (without bronchodilator)
Beschreibung

Physiology Pulmonary

Datentyp

text

Alias
UMLS CUI [1,1]
C0031842
UMLS CUI [1,2]
C0024109
Observational study outcomes
Beschreibung

Observational study outcomes

Alias
UMLS CUI-1
C1518527
UMLS CUI-2
C0086749
cACT (childhood Asthma Control Test)
Beschreibung

Composite Scores

Datentyp

text

Alias
UMLS CUI [1,1]
C0449820
UMLS CUI [1,2]
C0205199
Events in the 12 months prior to study entry:
Beschreibung

Exacerbation of asthma

Datentyp

text

Alias
UMLS CUI [1]
C0349790
History of:
Beschreibung

Utilization healthcare; Costs healthcare

Datentyp

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
Beschreibung

medication asthma

Datentyp

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Spirometry (pre­ and post­ bronchodilator)
Beschreibung

Physiology Pulmonary

Datentyp

text

Alias
UMLS CUI [1,1]
C0031842
UMLS CUI [1,2]
C0024109
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Table III- Core Asthma Outcomes NIH AHRQ for children (5­11 years of age)

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Characterization of study population for prospective clinical trials
C2348561 (UMLS CUI-1)
C1880022 (UMLS CUI-2)
C0008976 (UMLS CUI-4)
Biomarkers Serologic
Item
Serologic multi­allergen screen (IgE) to define atopic status (also for observational studies)
text
C0005516 (UMLS CUI [1,1])
C0205473 (UMLS CUI [1,2])
Composite Scores
Item
cACT (childhood Asthma Control Test)
text
C0449820 (UMLS CUI [1,1])
C0205199 (UMLS CUI [1,2])
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma (1)
CL Item
Asthma­-specific hospital admissions (2)
CL Item
Asthma­-specific ED visits (separate UC visits when these can be differentiated) (3)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions (1)
CL Item
Asthma­-specific ED visits (2)
CL Item
Asthma-­specific outpatient visits (3)
CL Item
Asthma-­specific medication use (4)
Physiology Pulmonary
Item
Spirometry (pre­ and post­ bronchodilator)
text
C0031842 (UMLS CUI [1,1])
C0024109 (UMLS CUI [1,2])
Item Group
Prospective clinical trial efficacy/ effectiveness outcomes
C0008976 (UMLS CUI-1)
C1280519 (UMLS CUI-2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
 Systemic corticosteroids for asthma (1)
CL Item
Asthma-­specific hospital admissions (2)
CL Item
 Asthma-­specific ED visits (separate UC visits when these can be differentiated) (3)
CL Item
Asthma-­specific ICU admissions/intubations (4)
CL Item
 Death (all cause and asthma related) (5)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions  (1)
CL Item
Asthma­-specific ED visits  (2)
CL Item
Asthma-­specific outpatient visits  (3)
CL Item
Asthma-­specific detailed medication use (name, dose, duration) (4)
CL Item
Resource use related to the intervention (eg, personnel time, mite eradication, equipment) (5)
medication asthma
Item
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
text
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Physiology Pulmonary
Item
Spirometry (without bronchodilator)
text
C0031842 (UMLS CUI [1,1])
C0024109 (UMLS CUI [1,2])
Item Group
Observational study outcomes
C1518527 (UMLS CUI-1)
C0086749 (UMLS CUI-2)
Composite Scores
Item
cACT (childhood Asthma Control Test)
text
C0449820 (UMLS CUI [1,1])
C0205199 (UMLS CUI [1,2])
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma (1)
CL Item
Asthma­-specific hospital admissions (2)
CL Item
Asthma­-specific ED visits (separate UC visits when these can be differentiated) (3)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions  (1)
CL Item
Asthma­-specific ED visits  (2)
CL Item
Asthma-­specific outpatient visits  (3)
CL Item
Asthma-­specific detailed medication use (name, dose, duration) (4)
CL Item
Resource use related to the intervention (eg, personnel time, mite eradication, equipment) (5)
medication asthma
Item
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
text
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Physiology Pulmonary
Item
Spirometry (pre­ and post­ bronchodilator)
text
C0031842 (UMLS CUI [1,1])
C0024109 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video